The S&P 500 Bearly Budges as Scariest Month of Year for Stocks Begins
The S&P 500 (Index: SPX) was nearly unchanged over the past week. The index dipped 0.28% from where it closed the preceding Friday, winding up the trading week ending on Friday, 2 October 2026 at 7,722.72.
While it might seem mostly balanced, that tiny, bearish change is masking some much bigger changes within the index over the past month.
That difference can be seen by comparing the trajectories of the regular market cap-weighted index and the equal-weighted version of the S&P 500, which we’ll represent with Invesco’s S&P 500 Equal Weight ETF (NYSE: RSP). The market cap-weighted S&P 500 declined 0.32% over the month from 3 September 2026 to 2 October 2026, while the equal-weighted version of the S&P 500 fell 4.69%.
The difference between the two versions of the S&P 500 index is being driven by the global bond rout that’s been taking place over this time, which has seen U.S. long-term bond yields rise as both Japan and France have seen their bond yields spike as both are experiencing debt crises.
In the U.S., the ongoing global bond rout has pushed up the yields of U.S. Treasuries to their highest levels in decades, also boosting U.S. interest rates. Consequently, interest rate sensitive stocks in the S&P 500 have been beaten down as bond yield have risen, subjecting the overall index to downward forces.
But the market cap-weighted S&P 500 has avoided plunging because it is being buoyed up by big tech stocks from the companies making big investments in Artificial Intelligence (AI) technologies, whose stock prices have increased in this period. The rise of big AI stocks is mostly offsetting the gravitational pull of the global bond rout. At least, so far.
The following chart shows the divergence between the market cap-weighted S&P 500 and the equal-weighted version of the index.
The latest update of the dividend futures-based model‘s alternative futures chart shows the battle between rising AI tech stocks and all other stocks is keeping the index right about where it would be expected to be provided investors are focusing on the now current quarter of 2026-Q4 in setting overall stock prices.
Here is our sampling of the random onset of new information that moved markets during the trading week ending on 2 October 2026 as the scariest month for stocks gets underway.
- Monday, 28 September 2026
-
- Signs and portents for the U.S. economy:
- Oil prices jump over 4% as Trump rejects Iranian proposal to reopen Strait of Hormuz
- Bigger trouble, stimulus developing in China:
- China’s cabinet pledges stronger policy support to meet growth target
- BOJ minions thinking about hiking Japan’s interest rates more often because of inflation, JapanGov minion hints at more interventions to prop up currency:
- Bank of Japan debated need for faster rate hikes, July minutes show
- Japan’s corporate services inflation hits 2-year high
- Japan’s currency diplomat Mimura urges markets to heed ‘very clear’ warning on yen
- ECB minions thinking about fighting Eurozone inflation, slowly:
- Stocks fall as higher oil prices, Treasury yields weigh
- Gold and silver prices fall sharply as higher bond yields weigh on metals
- Tuesday, 29 September 2026
-
- Signs and portents for the U.S. economy:
- China, US pledge tariff cuts on $60 billion of goods including agriculture, toys, toasters
- Target lowers prices on nearly 2,000 items ahead of holiday season
- Oil falls as investors focus on Middle East supply
- Medicare Advantage premiums expected to drop more than 16% in 2027, CMS projects
- US single-family home prices rise in July, FHFA says
- Fed rate hike odds tumble to coin flip after Williams says no rush
- Fed minions see more inflation ahead, not so sure about another rate hike, and worry about not saying enough:
- Fed’s Cook sees further inflationary pressures ahead
- Fed’s Barr says more rate hikes likely to be needed to curb inflation
- Fed’s Williams sees no urgency for next Fed rate hike
- Prospect of Fed pulling too far back on communications poses volatility risk, Musalem says
- Bigger trouble, stimulus developing in China:
- China’s AI agents can lie and scheme – just like their US rivals
- China unveils rate cut, mortgage subsidies to spur growth
- China expects trade to grow despite external challenges
- China’s Golden Week travel surge masks cautious consumer spending
- China factories seen rebounding in September as Beijing signals more aid
- ECB minions thinking about how to make Euro currency more popular:
- U.S. equities closed in the red as oil prices slipped and yields remained in focus
- Wednesday, 30 September 2026
-
- Signs and portents for the U.S. economy:
- US second-quarter GDP revised higher amid robust consumer spending
- US goods trade deficit widens sharply in August
- Oil prices rise by about $1/bbl on stalled US-Iran talks and tight fuel markets
- Fed now expected to sit on hands rather than hike U.S. interest rates quite so soon:
- Fed minion says inflation Fed minions have allowed on their watch for years is too damn high:
- Former chief minion’s overspending on headquarters remodel was bad management, not criminal
- AI-related growth signs developing in China:
- Chinese factory activity expands in September amid AI boom
- China services growth hits three-month high, private PMI shows
- BOJ minions thinking harder about hiking Japan’s interest rates more often:
- Bigger trouble developing in Eurozone:
- ECB minions standing by to leap into action, chief minion thinking hard about next career move:
- Price expectations and demand key in ECB’s next move, Schnabel says
- ECB’s Lagarde says it ‘would not be a good idea’ to run for French president
- S&P 500 dips, Nasdaq higher on modest rise in inflation
- Thursday, 1 October 2026
-
- Signs and portents for the U.S. economy:
- US mortgage rates jump by most in 4 years in latest week
- US manufacturing steady in September, input prices increase
- Oil prices rise 2% as China suspends fuel exports
- US construction spending surges in August
- Fed minions say they would like to see lower inflation. And maybe a half point rate hike, but not in October:
- Fed’s Cook sees AI inflationary push as a top 2027 risk
- Fed’s Logan calls for ’50 bps or more’ in rate hikes
- Bigger trouble developing out of China:
- Bigger trouble developing in Eurozone:
- China driving worrying rise in EU imports, Commission official says
- S&P 500 closes higher to start October as Treasury yields retreat from multiyear highs updates
- Friday, 2 October 2026
-
- Signs and portents for the U.S. economy:
- Oil settles lower after Europe agrees to tap diesel reserves
- US tells France and Germany to release diesel stocks or face US export ban
- Trump: not going to be doing diesel export ban
- US factory orders increase slightly in August
- Fed minions expected to take October 2026 rate hike off the table, Fed minions seem confused about next actions:
- Fed’s Goolsbee says rate hike and pause both ‘on the table’
- Bigger trouble developing out of China:
- Bigger trouble developing in Japan, BOJ minions get data supporting their plans to hike Japan’s interest rates more:
- Japan’s unemployment rate rises to 2.5% in August, above expectations
- Tokyo core inflation rate jumps in September, bolsters case for more BOJ hikes
- Bigger trouble developing in Eurozone, ECB minions counting on Eurozone debt crisis to counter inflation:
- Euro zone inflation surges more than expected
- ECB’s Rehn says soaring yields may curb inflation impact of expensive energy
- S&P 500 ends week lower despite Friday rally
The CME Group’s FedWatch Tool no longer anticipates a quarter point rate hike when the Fed meets to consider how to set the Federal Funds Rate on 28 October (2026-Q4). Instead, it now anticipates the Fed’s next adjustment to interest rates will still be a quarter point increase, coming when the Fed meets on 9 December (2026-Q4).
Looking beyond that date, the FedWatch Tool projects the Fed will keep hiking rates a quarter point at a time at twelve-week intervals, with at least three rate hikes predicted in 2027. Those forecast hikes would be announced on 17 March (2027-Q1), 9 June (2027-Q2) and 15 September (2027-Q3).
The Atlanta Fed’s GDPNow tool‘s projection of real GDP growth for the U.S. economy in 2026-Q3 declined to 3.7%, falling from the +5.0% annualized growth it forecast a week earlier.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull and bear examining a perfectly balanced scale labeled ‘AI STOCKS’ (green pan) and ‘ALL OTHER STOCKS’ (red pan), set against a Wall Street background.”
Source: https://politicalcalculations.blogspot.com/2026/10/the-s-500-bearly-budges-as-scariest.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.




